A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis

Last updated: January 15, 2020
Sponsor: Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
Overall Status: Active - Recruiting

Phase

2

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04231292
SZSBE-RD01-HD-II-01
  • Ages 18-75
  • All Genders

Study Design

Total Participants: 105
Study Start date:
March 01, 2020
Estimated Completion Date:
December 31, 2022

Connect with a study center

  • Renal Rheumatology and Immunology department Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai 200092
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.